JP2009523142A5 - - Google Patents

Download PDF

Info

Publication number
JP2009523142A5
JP2009523142A5 JP2008549783A JP2008549783A JP2009523142A5 JP 2009523142 A5 JP2009523142 A5 JP 2009523142A5 JP 2008549783 A JP2008549783 A JP 2008549783A JP 2008549783 A JP2008549783 A JP 2008549783A JP 2009523142 A5 JP2009523142 A5 JP 2009523142A5
Authority
JP
Japan
Prior art keywords
alkoxy
alkyl
aryl
halogen
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008549783A
Other languages
English (en)
Japanese (ja)
Other versions
JP5249782B2 (ja
JP2009523142A (ja
Filing date
Publication date
Priority claimed from FR0600344A external-priority patent/FR2896159B1/fr
Application filed filed Critical
Publication of JP2009523142A publication Critical patent/JP2009523142A/ja
Publication of JP2009523142A5 publication Critical patent/JP2009523142A5/ja
Application granted granted Critical
Publication of JP5249782B2 publication Critical patent/JP5249782B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008549783A 2006-01-13 2006-12-18 トリアジン誘導体およびインスリン増感剤の組合せ Active JP5249782B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0600344A FR2896159B1 (fr) 2006-01-13 2006-01-13 Combinaison de derives de triazine et d'agents sensibilisateurs a l'insuline.
FR06/00344 2006-01-13
PCT/EP2006/012185 WO2007079917A2 (en) 2006-01-13 2006-12-18 Combination of triazine derivatives and insulin sensitisers

Publications (3)

Publication Number Publication Date
JP2009523142A JP2009523142A (ja) 2009-06-18
JP2009523142A5 true JP2009523142A5 (enExample) 2010-02-12
JP5249782B2 JP5249782B2 (ja) 2013-07-31

Family

ID=36654309

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008549783A Active JP5249782B2 (ja) 2006-01-13 2006-12-18 トリアジン誘導体およびインスリン増感剤の組合せ

Country Status (22)

Country Link
US (2) US8791115B2 (enExample)
EP (1) EP1971330B1 (enExample)
JP (1) JP5249782B2 (enExample)
KR (2) KR20140033498A (enExample)
CN (1) CN101355933A (enExample)
AR (1) AR059032A1 (enExample)
AT (1) ATE476179T1 (enExample)
AU (1) AU2006334734B2 (enExample)
BR (1) BRPI0620985B8 (enExample)
CA (1) CA2640897C (enExample)
CY (1) CY1110789T1 (enExample)
DE (1) DE602006016014D1 (enExample)
DK (1) DK1971330T3 (enExample)
EA (1) EA015576B1 (enExample)
ES (1) ES2347177T3 (enExample)
FR (1) FR2896159B1 (enExample)
IL (1) IL192558A (enExample)
PL (1) PL1971330T3 (enExample)
PT (1) PT1971330E (enExample)
SI (1) SI1971330T1 (enExample)
WO (1) WO2007079917A2 (enExample)
ZA (1) ZA200806947B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2896159B1 (fr) * 2006-01-13 2008-09-12 Merck Sante Soc Par Actions Si Combinaison de derives de triazine et d'agents sensibilisateurs a l'insuline.
JP5667985B2 (ja) * 2008-12-12 2015-02-12 ポクセル インスリンとトリアジンの組合せ及び糖尿病を治療するためのその使用
CA2745854A1 (en) * 2008-12-12 2010-06-17 Daniel Cravo Tetrahydrotriazine compounds for treating diseases associated with ampk activity
FR2948027A1 (fr) * 2009-07-17 2011-01-21 Merck Sante Sas Derives amines de dihydro-1,3,5-triazine pour leur utilisation dans le traitement des maladies associees a une ischemie et/ou une reperfusion
FR2948026B1 (fr) * 2009-07-17 2011-12-02 Merck Sante Sas Derives amines de dihydro-1,3,5-triazine
TWI436768B (zh) * 2010-06-09 2014-05-11 Poxel 第２型糖尿病之治療
KR20120011667A (ko) 2010-07-29 2012-02-08 광주과학기술원 당뇨병 치료제의 스크리닝 방법
KR101271218B1 (ko) * 2012-12-07 2013-06-07 광주과학기술원 당뇨병 치료제의 스크리닝 방법
JP2020536121A (ja) 2017-10-02 2020-12-10 ポクセルＰｏｘｅｌ 駆出率が保持された心不全を治療する方法
CA3102412A1 (en) 2018-06-06 2019-12-12 Metavant Sciences Gmbh Methods of treating subjects having diabetes with chronic kidney disease
WO2019238647A1 (en) 2018-06-14 2019-12-19 Poxel Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288095B1 (en) * 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
US5885980A (en) * 1996-06-25 1999-03-23 Enrique G. Gutierrez Composition and method for treating diabetes
US6011049A (en) 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
TW200514783A (en) 1999-09-22 2005-05-01 Bristol Myers Squibb Co Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method
AR030920A1 (es) 1999-11-16 2003-09-03 Smithkline Beecham Plc Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones
FR2804113B1 (fr) * 2000-01-26 2004-06-18 Lipha Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique
AU2001257456B2 (en) * 2000-05-01 2006-02-09 Aeropharm Technology, Inc. A core formulation
FR2853650B1 (fr) * 2003-04-10 2006-07-07 Merck Sante Sas Procede de dedoublement d'amines utiles pour le traitement de desordres associes au syndrome d'insulino-resistance
TW200526678A (en) * 2003-08-01 2005-08-16 Janssen Pharmaceutica Nv Substituted indole-O-glucosides
FR2863484B1 (fr) * 2003-12-11 2007-04-13 Oreal Utilisation de composes capables d'agir sur la voie metabolique controlee par la dopachrome tautomerase trp-2 comme agent protecteur des melanocytes du follicule pileux et applications
EP1841414A1 (en) * 2003-12-31 2007-10-10 Alpharma, Inc. Rosiglitazone and metformin formulations
FR2896159B1 (fr) * 2006-01-13 2008-09-12 Merck Sante Soc Par Actions Si Combinaison de derives de triazine et d'agents sensibilisateurs a l'insuline.

Similar Documents

Publication Publication Date Title
RU2403258C2 (ru) Тиазолилдигидроиндазолы
US10577337B2 (en) Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof
RU2350605C2 (ru) Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ
TW200736232A (en) Pyrimidine derivatives
JP2004516314A5 (enExample)
JP2006515858A5 (enExample)
JP2009504763A5 (enExample)
GB0612423D0 (en) Therapeutic agents
AR064304A1 (es) Formulaciones de ansamicina y sus metodos de uso
JP2009523142A5 (enExample)
RU2009102535A (ru) Производные карбамидов тропана, их получение и их применение в терапии
RU2009144538A (ru) Новые циклические пептидные соединения
NO20073405L (no) Farmasoytisk utforming inneholdende en frigjoringshastighetskontrollerende sammensetning
TW200612936A (en) Indole derivatives
WO2018075959A4 (en) Methods using hdac11 inhibitors
JP2009523139A5 (enExample)
JP2019527724A5 (enExample)
NO20075617L (no) 4-fenyl-5-okso-1,4,5,6,7,8-heksahydrokinolinderivater for behandling av infertilitet
TW200616979A (en) Non-nucleoside reverse transcriptase inhibitors
RU2009102270A (ru) Производные тиазолилмочевины в качестве ингибиторов фосфатидилинозитол-3-киназы
RU2012129887A (ru) Ингибиторы мк2
JP2009523141A5 (enExample)
HRP20151419T1 (hr) Derivati 2-okso-1-imidazolidinil imidazotiadiazola
JP2009523140A5 (enExample)
JP2016536372A5 (enExample)